Additionally, plasma levels of CXCL13 in this study were significantly higher in the patients with detectable cross-neutralization activity compared to patients without detectable cross-neutralization activity at different time points during acute HIV-1 infection, suggesting a role for CXCL13 in predicting the emergence of cross-neutralization antibodies. This evidence concerns the gene CXCL13 and HIV-1 infection.